Immediate Impact
9 from Science/Nature 54 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Tumour vasculature at single-cell resolution
2024 StandoutNature
Works of Robert E. Emerson being referenced
Reclassification of serous ovarian carcinoma by a 2‐tier system
2011
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robert E. Emerson | 762 | 719 | 620 | 72 | 2.3k | |
| Hermann Rogatsch | 612 | 1084 | 765 | 80 | 2.5k | |
| Delia Pérez‐Montiel | 613 | 1016 | 901 | 124 | 2.4k | |
| Muhammad T. Idrees | 1122 | 928 | 766 | 135 | 2.0k | |
| Bonnie Balzer | 388 | 870 | 322 | 78 | 2.1k | |
| Yoav H. Messinger | 1601 | 1154 | 810 | 103 | 3.4k | |
| Gloria A. Niehans | 689 | 627 | 827 | 45 | 2.1k | |
| Michael R. Pins | 717 | 783 | 859 | 68 | 2.2k | |
| Aurore Coulomb L’Herminé | 340 | 643 | 684 | 75 | 2.2k | |
| Joseph T. Rabban | 563 | 672 | 678 | 115 | 3.4k | |
| Francisco F. Nogales | 1012 | 561 | 407 | 134 | 2.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...